Showing results (1351-1360 of 1,380) with videos related to

Sort By:
Pageof 138
JCO Precision Oncology|September 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis PredictionEric D Whitman, Vadim P Koshenkov, Brian R Gastman, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
BMP9 regulates the endothelial secretome to drive pulmonary hypertensionYing Zhong, Peiran Yang, Luca Troncone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2018
Late-onset Sepsis in Preterm Infants Can Be Detected Preclinically by Fecal Volatile Organic Compound Analysis: A Prospective, Multicenter Cohort StudyDaniel J C Berkhout, Britt J van Keulen, Hendrik J Niemarkt, et al.
Systematic and Applied Microbiology|August 2, 2025
Nitrogen fixation in Pampinifervens, a new species-rich genus of Aquificaceae that inhabits a wide pH range in terrestrial hot springsMarike Palmer, Nancy O Nou, Lara A Turello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination StrategiesMatthew C Stubbs, Timothy C Burn, Richard Sparks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2020
Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell MalignancyNiu Shin, Matthew Stubbs, Holly Koblish, et al.
Journal of Medicinal Chemistry|January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancerWenqing Yao, Jincong Zhuo, David M Burns, et al.
Cancer Discovery|March 7, 2022
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 InhibitorHolly K Koblish, Liangxing Wu, Liang-Chuan S Wang, et al.
Journal of Medicinal Chemistry|January 8, 2025
Discovery of INCB159020, an Orally Bioavailable KRAS G12D InhibitorQinda Ye, Artem Shvartsbart, Zhenwu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical PhenotypeMaeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Pageof 138